TY - JOUR
T1 - Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort
AU - Tazelaar, Gijs HP.
AU - Dekker, Annelot M.
AU - van Vugt, Joke JFA.
AU - van der Spek, Rick A.
AU - Westeneng, Henk-Jan
AU - Kool, Lindy JBG.
AU - Kenna, Kevin P.
AU - van Rheenen, Wouter
AU - Pulit, Sara L.
AU - McLaughlin, Russell L.
AU - Sproviero, William
AU - Iacoangeli, Alfredo
AU - Hübers, Annemarie
AU - Brenner, David
AU - Morrison, Karen E.
AU - Shaw, Pamela J.
AU - Shaw, Christopher E.
AU - Panadés, Monica Povedano
AU - Mora Pardina, Jesus S.
AU - Glass, Jonathan D.
AU - Hardiman, Orla
AU - Al-Chalabi, Ammar
AU - van Damme, Philip
AU - Robberecht, Wim
AU - Landers, John E.
AU - Ludolph, Albert C.
AU - Weishaupt, Jochen H.
AU - van den Berg, Leonard H.
AU - Veldink, Jan H.
AU - van Es, Michael A.
AU - Project MinE ALS Sequencing Consortium
PY - 2018/9/22
Y1 - 2018/9/22
N2 - NIPA1 (non-imprinted in Prader-Willi/Angelman syndrome 1) mutations are known to cause Hereditary Spastic Paraplegia type 6, a neurodegenerative disease that phenotypically overlaps to some extent with Amyotrophic Lateral Sclerosis. Previously, a genome-wide screen for copy number variants found an association with rare deletions in NIPA1 and ALS, and subsequent genetic analyses revealed that long (or expanded) polyalanine repeats in NIPA1 convey increased ALS susceptibility. We set out to perform a large-scale replication study to further investigate the role of NIPA1 polyalanine expansions with ALS, in which we characterized NIPA1 repeat size in an independent international cohort of 3,955 ALS patients and 2,276 unaffected controls and combined our results with previous reports. Meta-analysis on a total of 6,245 ALS patients and 5,051 controls showed an overall increased risk of ALS in those with expanded (>8) GCG-repeat length (odds ratio = 1.50, P = 3.8x10-5). Together with previous reports, these findings provide evidence for an association of an expanded polyalanine repeat in NIPA1 and ALS.
AB - NIPA1 (non-imprinted in Prader-Willi/Angelman syndrome 1) mutations are known to cause Hereditary Spastic Paraplegia type 6, a neurodegenerative disease that phenotypically overlaps to some extent with Amyotrophic Lateral Sclerosis. Previously, a genome-wide screen for copy number variants found an association with rare deletions in NIPA1 and ALS, and subsequent genetic analyses revealed that long (or expanded) polyalanine repeats in NIPA1 convey increased ALS susceptibility. We set out to perform a large-scale replication study to further investigate the role of NIPA1 polyalanine expansions with ALS, in which we characterized NIPA1 repeat size in an independent international cohort of 3,955 ALS patients and 2,276 unaffected controls and combined our results with previous reports. Meta-analysis on a total of 6,245 ALS patients and 5,051 controls showed an overall increased risk of ALS in those with expanded (>8) GCG-repeat length (odds ratio = 1.50, P = 3.8x10-5). Together with previous reports, these findings provide evidence for an association of an expanded polyalanine repeat in NIPA1 and ALS.
KW - Amyotrophic lateral sclerosis
KW - NIPA1
KW - Repeat expansion
U2 - 10.1016/j.neurobiolaging.2018.09.012
DO - 10.1016/j.neurobiolaging.2018.09.012
M3 - Article
SN - 0197-4580
JO - Neurobiology of Aging
JF - Neurobiology of Aging
ER -